Physician profile
Saiyad A Sarkar
NPI 1689654824
$34,641.86
in general payments reported to CMS, 2019-2025
8 companies · $7,036 in 2025
The $7,036 reported for 2025 was more than what 91% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,555 · 2020: $780 · 2022: $3,081 · 2023: $3,532 · 2024: $12K · 2025: $7,036.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,400 · Travel and Lodging: $5,607 · Education: $5,425 · Food and Beverage: $2,794.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,400.00 |
| Travel and Lodging | $5,606.94 |
| Education | $5,425.00 |
| Food and Beverage | $2,793.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noah Medical Corporation | $19,178.65 | 2023-2025 | Galaxy |
| Merit Medical Systems INC | $8,142.46 | 2019-2020 | |
| Intuitive Surgical, INC. | $6,905.71 | 2019-2025 | Da Vinci Surgical System |
| Pulmonx Corporation | $194.67 | 2019-2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Galvanize Therapeutics, INC | $137.17 | 2024 | Aliya System |
| Olympus America INC. | $58.71 | 2025 | |
| Baxter Healthcare | $12.79 | 2023 | Hillrom - Life 2000 Ventilation System |
| Covidien Lp | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saiyad Sarkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.